1. Pink Sheet
  2. >>R&D
  3. >>Clinical Trials

How Merck Plans To Protect Commercial Info Under EU Clinical Trial Rules

 
• By Vibha Sharma

In the second segment of a two-part article on transparency provisions for the new EU clinical trial portal, a senior Merck executive explains how the company will ensure that commercially sensitive information and personal data in its clinical trial applications are not made public.

Clinical trial
EU CTR Will Usher In A New Era For Clinical Trial Transparency • Source: Shutterstock

Merck KGaA has embarked on a mammoth two-part initiative to prepare for the expanded transparency requirements that will be embedded in the new EU Clinical Trial Information System (CTIS) when it goes live in December 2021.

Part one of the initiative involves reviewing and re-writing, where possible, all clinical trial-related templates and documents to reduce or eliminate

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Clinical Trials

More from R&D